Cobalt

Cobalt has been studied in 75 papers since 2017: 70 observational studies in people, 1 in animals, 2 in cells, 2 reviews; 26 in the past year. The newest story, Nov 2, 2026: “Urinary cadmium linked to higher immune marker levels”.

InterventionHuman trials

75 papers study it25 findingsUpdated

MeSH

Research on it is growing 29% faster than aging research as a whole: 10 papers in the latest year counted

4 new papers in 30 daysSee all 74 papers on cobalt

At a glance

The findings reach people, from one lab or study. 14 independent labs in 4 countries; 1 trial, none about aging.

“Co (OR for Q4: 2.33, 95% CI: 1.27–4.26) were all significantly positively associated with the risk of NMSC”
Association between urinary heavy metals and non-melanoma skin cancer: Insights from a population-based studyResearch Square2026doi:10.21203/rs.3.rs-10032616/v1

None of its findings points the other way.

Cells and humans: a single group. Worms or flies and mice: nothing yet.
  • 14 independent labs in 4 countries
  • 1 trial, none about aging
  • Funders: National Natural Science Foundation of China and others
  • 1 of 24 findings with company ties
  • Humans69
  • Animals1
  • Cells2

What did studies of cobalt find?

8

Studies of cobalt measured 8 outcomes, among them Mini-Mental State Examination, senescence-associated secretory phenotype (SASP) and cellular senescence.

Mini-Mental State Examination

downin humans1

1 study
  1. Cobalt is linked with worse Mini-Mental State Examination in humans (higher blood Co levels, recall domain) (β=-0.061, 95% CI: -0.091, -0.031).

    Humanshigher blood Co levels, recall domainbloodup to 7.8 yearsn = 6,868

More on Mini-Mental State Examination

Senescence-associated secretory phenotype (SASP)

upin human cells1

1 study
  1. Cobalt increases senescence-associated secretory phenotype (SASP) in human cells (prolonged exposure).

    Cellsprolonged exposuresynovial fibroblast-like cells

More on Senescence-associated secretory phenotype (SASP)

Cellular senescence

upin human cells1

1 study
  1. Cobalt induces cellular senescence in human cells (prolonged exposure).

    Cellsprolonged exposuresynovial fibroblast-like cells

More on Cellular senescence

CAT

downin human cells1

1 study
  1. Cobalt decreases CAT in human cells (prolonged exposure).

    Cellsprolonged exposuresynovial fibroblast-like cells

More on CAT

Fasting plasma glucose

downin humans1

1 study
  1. Cobalt is linked with lower fasting plasma glucose in older adults without hyperlipemia and in women.

    Humansin older adults without hyperlipemia and in womenn = 2,348

More on Fasting plasma glucose

TNF-alpha

upin humans1

1 study
  1. Cobalt is linked with higher TNF-alpha in humans (cross-sectional association with 8-iso-PGF2α in parallel).

    Humanscross-sectional association with 8-iso-PGF2α in paralleln = 420

More on TNF-alpha

LDL-C

upin humans1

1 study
  1. Cobalt is linked with higher LDL-C in humans (cross-sectional association; per 1-unit increase in serum Co) (0.571 mmol/L per 1-unit increase in serum Co).

    Humanscross-sectional association; per 1-unit increase in serum Coper 1-unit increase in serum Con = 420

More on LDL-C

DNA methylation

no changein humans1

1 study
  1. Cobalt was not clearly linked with DNA methylation in humans (blood chromium and cobalt levels).

    Humansblood chromium and cobalt levelswhole blood

More on DNA methylation

What is cobalt linked with?

17

Studies link cobalt with 17 measures, among them PR interval, hypertension prevalence and non-melanoma skin cancer.

PR interval

downin humans1

1 study
  1. Cobalt is associated with PR interval in humans (single-element models) (−1.40% PR interval per IQR increase (95% CI: -2.67%, −0.12%)).

    Humanssingle-element modelseach IQR increasen = 80

More on PR interval

Hypertension prevalence

downin humans1OR 0.256

1 study
  1. Cobalt is associated with hypertension prevalence in humans (Lead-exposed workers in northwestern China) (OR 0.256, 95% CI 0.108–0.588).

    HumansLead-exposed workers in northwestern Chinan = 419

More on Hypertension prevalence

Non-melanoma skin cancer

upin humans1OR 2.33

1 study
  1. Cobalt is linked with a higher risk of non-melanoma skin cancer in humans (quartile 4 vs quartile 1) (OR 2.33, 95% CI 1.27–4.26).

    Humansquartile 4 vs quartile 1

More on Non-melanoma skin cancer

Breast cancer

upin humans1RR 1.08

1 study
  1. Cobalt is linked with a higher risk of breast cancer in humans (residential exposure over a 10-year pre-diagnosis window) (adjusted RR 1.08, 95% CI: 1.05, 1.11).

    Humansresidential exposure over a 10-year pre-diagnosis window10-year pre-diagnosis windowfemales

More on Breast cancer

Neurological mortality

upin humans1+137%

1 study
  1. Cobalt is linked with a higher risk of neurological mortality in humans (highest vs lowest quartile of urinary cobalt) (137.1%).

    Humanshighest vs lowest quartile of urinary cobalt4.754 yearsn = 9,727

Cardiovascular mortality

upin humans1+25%

1 study
  1. Cobalt is linked with a higher risk of cardiovascular mortality in humans (highest vs lowest quartile of urinary cobalt) (24.8%).

    Humanshighest vs lowest quartile of urinary cobalt4.754 yearsn = 9,727

Mortality

upin humans1HR 1.292

1 study
  1. Cobalt is linked with a higher risk of mortality in humans (highest vs lowest quartile of urinary cobalt) (HR: 1.292, 95% CI: 1.155-1.445).

    Humanshighest vs lowest quartile of urinary cobalt4.754 yearsn = 9,727

Cognitive impairment

upin humans1HR 1.656

1 study
  1. Cobalt is linked with a higher risk of cognitive impairment in humans (highest blood Co quartile versus Q1) (Adjusted HR 1.656 (95% CI 1.366-2.008)).

    Humanshighest blood Co quartile versus Q1bloodup to 7.8 yearsn = 6,868

More on Cognitive impairment

Cardiovascular-kidney-metabolic syndrome

upin humans1

1 study
  1. Cobalt is linked with a higher risk of cardiovascular-kidney-metabolic syndrome in humans (+14% higher risk per 1-unit increase).

    Humansn = 6,249

More on Cardiovascular-kidney-metabolic syndrome

Cardiovascular disease

upin humans1

1 study
  1. Cobalt is linked with a higher risk of cardiovascular disease in humans (per IQR increase via longitudinal trajectory of CAC) (21 (6, 39) per 100,000 person-years).

    Humansper IQR increase via longitudinal trajectory of CAC

More on Cardiovascular disease

All 17

Has cobalt been tested in people?

0 of 1 about aging

Yes: 70 observational studies in people have been published, and 1 trial is registered.

In trials

Trial sponsors

Funding

2 grants since 2018

National Institute for Health Research£1.9MNational Institute of Mental Health$93.8K

Contains public sector information licensed under the Open Government Licence v3.0.

Latest

Dec 2025: 3Jan 2026: 2Feb 2026: 3Mar 2026: 0Apr 2026: 2May 2026: 1Jun 2026: 3Jul 2026: 0Aug 2026: 2Sep 2026: 3Oct 2026: 2Nov 2026: 425 papers in 12 months
Journal of the American Heart Association

Urinary cadmium linked to higher immune marker levels

An increase in urinary cadmium spanning the middle half of measured levels was associated with 7.99% higher levels of an immune-activation marker.An increase in urinary cadmium spanning the middle half of measured levels was associated with 7.99% higher levels of an immune-activation marker.

Cohort · 5,148 peoplePopulations
Scientific Reports

Metal mixtures linked to abnormal blood fats in older adults

An observational study comparing 436 new cases with 872 controls during 2019–2023 linked urinary metal mixtures to dyslipidemia, or abnormal blood fat levels.An observational study comparing 436 new cases with 872 controls during 2019–2023 linked urinary metal mixtures to dyslipidemia, or abnormal blood fat levels.

Case-control studyPopulations

See all 74 papers on cobalt